Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5,6-Dihydro-2''-deoxyuridine is a nucleoside analog that plays a significant role in various applications, particularly in the field of molecular biology and pharmaceuticals. It is known for its ability to interact with nucleic acids, such as RNA, and has potential implications in the treatment of diseases, disorders, or conditions related to these interactions.

5626-99-3

Post Buying Request

5626-99-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5626-99-3 Usage

Uses

Used in Molecular Biology Applications:
5,6-Dihydro-2''-deoxyuridine is used as a screening agent for binding to a nucleic acid target, such as an RNA or relevant fragment thereof, which may be implicated in a disease, disorder, or condition. This interaction can help identify potential therapeutic targets and contribute to the development of new treatments.
Used in Pharmaceutical Applications:
In the pharmaceutical industry, 5,6-Dihydro-2''-deoxyuridine is used as a key component in the development of drugs targeting RNA-related diseases. Its ability to bind to specific RNA sequences allows for the creation of targeted therapies that can potentially treat a wide range of conditions, including viral infections and genetic disorders.
Used in Diagnostic Applications:
5,6-Dihydro-2''-deoxyuridine can also be employed in the development of diagnostic tools, such as tests that detect the presence of specific RNA sequences in a patient's sample. This can aid in the early detection and diagnosis of diseases, enabling more timely and effective treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 5626-99-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,2 and 6 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5626-99:
(6*5)+(5*6)+(4*2)+(3*6)+(2*9)+(1*9)=113
113 % 10 = 3
So 5626-99-3 is a valid CAS Registry Number.
InChI:InChI=1/C18H13N3O4/c22-18-16(12-19-14-6-2-1-3-7-14)20-17(25-18)10-9-13-5-4-8-15(11-13)21(23)24/h1-12,19H

5626-99-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,6-DIHYDRODEOXYURIDINE

1.2 Other means of identification

Product number -
Other names 2'-deoxy-5,6-dihydrouridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5626-99-3 SDS

5626-99-3Upstream product

5626-99-3Relevant articles and documents

A Combined Experimental and Theoretical Approach to the Photogeneration of 5,6-Dihydropyrimidin-5-yl Radicals in Nonaqueous Media

Aparici-Espert, Isabel,Francés-Monerris, Antonio,Rodríguez-Mu?iz, Gemma M.,Roca-Sanjuán, Daniel,Lhiaubet-Vallet, Virginie,Miranda, Miguel A.

, p. 4031 - 4038 (2016)

The chemical fate of radical intermediates is relevant to understand the biological effects of radiation and to explain formation of DNA lesions. A direct approach to selectively generate the putative reactive intermediates is based on the irradiation of photolabile precursors. But, to date, radical formation and reactivity have only been studied in aqueous media, which do not completely mimic the microenvironment provided by the DNA structure and its complexes with proteins. Thus, it is also important to evaluate the photogeneration of nucleoside-based radicals in nonaqueous media. The attention here is focused on the independent generation of 5,6-dihydropyrimidin-5-yl radicals in organic solvent through the synthesis of new lipophilic tert-butyl ketone precursors. Formation of 5,6-dihydro-2′-deoxyuridin-5-yl and 5,6-dihydrothymidin-5-yl radicals has first been confirmed by using a new nitroxide-derived profluorescent radical trap. Further evidence has been obtained by nanosecond laser flash photolysis through detection of long-lived transients. Finally, the experimental data are corroborated by multiconfigurational ab initio CASPT2//CASSCF methodology.

USES OF DIHYDRO BASES

-

Paragraph 0099, (2014/08/06)

The present invention provides pharmaceutical compositions comprising a dihydro base described herein (e.g., compound DHdC). The dihydro base may show multiple tautomerism and may increase mutation of an RNA and/or DNA of a virus or cancer cell. The dihydro base may be used to reduce DNA methylation (e.g., in a cancer cell). The present invention also provides kits including the inventive pharmaceutical compositions and methods of treating a viral infection (e.g., influenza, HIV infection, or hepatitis C) or cancer using the pharmaceutical compositions or kits.

Direct strand scission from a nucleobase radical in RNA

Jacobs, Aaron C.,Resendlz, Marino J. E.,Greenberg, Marc M.

supporting information; experimental part, p. 3668 - 3669 (2010/05/15)

"Chemical equation presented" RNA oxidation is important in the etiology of disease and as a tool for studying the structure and folding kinetics of this biopolymer. Nucleobase radicals are the major family of reactive intermediates produced in RNA exposed to diffusible species such as hydroxyl radical. The nucleobase radicals are believed to produce direct strand breaks by abstracting hydrogen atoms from their own and neighboring ribose rings. By independently generating the formal C5 hydrogen atom addition product of uridine in RNA, we provide the first chemical characterization of the pathway for direct strand scission from an RNA nucleobase radical. The process is more efficient under anaerobic conditions. The preference for strand scission in double-stranded RNA over single-stranded RNA suggests that this chemistry may be useful for analyzing the secondary structure of RNA in hydroxyl radical cleavage experiments if they are carried out under anaerobic conditions.

Synthesis of deoxytetrahydrouridine

Norton, Jolanna,Matsuo, Hiroshi,Sturla, Shana J.

experimental part, p. 2221 - 2223 (2009/08/07)

The α-hydroxyamido functionality of 2 -deoxytetrahydrouridine (dTHU) makes this seemingly simple and generally useful compound difficult to obtain. Reported synthetic strategies produce extremely poor yields and multiple products, and full characterization data is not available. Described herein is a two-step approach for synthesizing dTHU in increased yields and purity; stability concerns are also addressed. Catalytic reduction (5% Rh/alumina) of 2 deoxyuridine, followed by reduction with sodium borohydride as a limiting reagent, produces dTHU and limits formation of side products. Evidence was obtained for formation of a methoxy-substituted analogue during purification. By this strategy, dTHU of >95% purity can be obtained in 40% yield on a 150 mg scale.

Selective fluorescence-based detection of dihydrouridine with boronic acids

Luvino, Delphine,Smietana, Michael,Vasseur, Jean-Jacques

, p. 9253 - 9256 (2008/02/10)

The first fluorescent sensing system for dihydrouridine detection is presented. Dihydrouridine is the single most frequently occurring post-transcriptional modification in tRNA from bacteria and eukaryotes. A series of 10 boronic acid derivatives was prepared and their fluorogenic behaviours towards dihydrouridine and uridine were investigated. Whereas uridine always quenches fluorescence via π-π stacking interactions, several boronic acid sensors have been found to show substantial fluorescence enhancement upon binding with dihydrouridine.

β-Selective synthesis of 2′-deoxy-5,6-dihydro-4-thiouridine, a precursor of the unstable nucleoside product of ionising radiation damage 2′-deoxy-5,6-dihydrocytidine

Peyrane, Frederic,Clivio, Pascale

, p. 1685 - 1689 (2007/10/03)

4-Thio oxathiaphosphepane nucleosides 2-4 undergo a rearrangement in pyridine that leads selectively to the β anomer of the 2′-deoxy-5,6- dihydro-4-thiouridine derivative 5. This diastereoselective reaction proceeds through a multistep mechanism initiated

Independent generation and study of 5,6-dihydro-2′-deoxyuridin-6-yl, a member of the major family of reactive intermediates formed in DNA from the effects of γ-radiolysis

Carter, K. Nolan,Greenberg, Marc M.

, p. 4275 - 4280 (2007/10/03)

Nucleobase radicals are the major family of reactive intermediates formed when nucleic acids are exposed to γ-radiolysis. Elucidation of their reactivity is complicated by the formation of multiple species randomly throughout the biopolymers. 5,6-Dihydro-2′-deoxyuridin-6-yl (1) was generated upon photolysis (350 nm) of the respective tert-butyl ketone (2). The radical abstracts hydrogen atoms from β-mercaptoethanol (k = 8.8 ± 0.5 × 106 M-1 s-1) and 2,5-dimethyltetrahydrofuran (k = 31 ± 2.5 M-1 s-1). The latter was used as a model for the 2-deoxyribose component of DNA. The major product formed in the presence of O2 was 6-hydroxy-5,6-dihydro-2′-deoxyuridine (11), which is believed to be formed directly from the peroxy precursor and not via elimination of superoxide. Small amounts of 2-deoxyribonolactone (13) were also formed under aerobic conditions. This product is believed to result from intramolecular hydrogen atom abstraction by the C6-peroxyl radical (14) and suggests that γ-radiolysis may indirectly result in oxidation of the C1′-position of nucleotides, despite the inaccessibility of this hydrogen in duplex DNA.

DNA damage induced via 5,6-dihydrothymid-5-yl in single-stranded oligonucleotides

Greenberg, Marc M.,Barvian, Mark R.,Cook, Gary P.,Goodman, Brian K.,Matray, Tracy J.,Tronche, Christopher,Venkatesan, Hariharan

, p. 1828 - 1839 (2007/10/03)

5,6-Dihydrothymid-5-yl (4) is generated via Norrish type I cleavage of isopropyl ketone 7. Ketone 7 was site specifically incorporated into chemically synthesized polythymidylates and an oligonucleotide containing all four native deoxyribonucleotides. No

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5626-99-3